Randomized Phase II Trial of the Sequences of Anthracyline and Taxane in Locally Advanced Breast Cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Docetaxel (Primary) ; Cyclophosphamide; Doxorubicin; Fluorouracil
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms NeoSAMBA
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 15 Nov 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 15 Nov 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Apr 2018.